Fredun Pharmaceuticals Limited (BOM:539730)
India · Delayed Price · Currency is INR 1,360.90
+0.70 (0.05%)
At close: Sep 25, 2026
Fredun Pharmaceuticals Market Cap
Fredun Pharmaceuticals has a market cap or net worth of 22.51 billion as of September 25, 2026. Its market cap has increased by 277.29% in one year.
Market Cap
22.51B
Enterprise Value
24.28B
Revenue
7.44B
Ranking
n/a
PE Ratio
57.96
Stock Price
1,360.90
ChartMarket Cap Chart
Since March 28, 2016, Fredun Pharmaceuticals's market cap has increased from 29.40M to 22.51B, an increase of 76,440.26%. That is a compound annual growth rate of 88.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 22.51B | 202.01% |
| Dec 31, 2025 | 7.45B | 115.10% |
| Dec 31, 2024 | 3.46B | -15.14% |
| Dec 29, 2023 | 4.08B | -20.69% |
| Dec 30, 2022 | 5.15B | 37.31% |
| Dec 31, 2021 | 3.75B | 116.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Unichem Laboratories | 38.74B |
| Kwality Pharmaceuticals | 38.10B |
| Hikal | 26.87B |
| Shukra Pharmaceuticals | 24.56B |
| Venus Remedies | 22.32B |
| Syncom Formulations (India) | 18.86B |
| Amrutanjan Health Care | 14.63B |
| TTK Healthcare | 14.57B |